Dr. Farah Yolanda Fourcand, MD

Dr. Fourcand practices at Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation.

Dr. Fourcand's NPI, 1013302421, was assigned on April 2, 2015. Dr. Fourcand graduated from FIU Herbert Wertheim College of Medicine in 2015. Dr. Fourcand holds Florida license ME164603.

Dr. Fourcand's primary practice is Cleveland Clinic Indian River Hospital, at 1000 36th St, Vero Beach, FL 32960 in Indian River County. The practice phone is (772) 567-4311.

Dr. Fourcand's primary practice is Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation. Dr. Fourcand is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Cleveland Clinic Indian River Hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fourcand practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Fourcand's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Fourcand is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Fourcand's licenses on file in 5 states: Florida, New Jersey, Maryland, District of Columbia and Virginia.

Dmand AI lists cerebrovascular disease and head injury among the conditions Dr. Fourcand treats.

CMS data shows 274 Medicare services from Dr. Fourcand across 5 procedure codes in 2024, for 165 Medicare patients. Medicare paid $24,395 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Dr. Fourcand in 2024. The largest group is 75 to 84, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fourcand's median patient age at 73, with 51% women.

In 2024, Dr. Fourcand wrote 179 Medicare Part D claims for 39 patients. 60% of them were for generic drugs. CMS names the drug for 96 of them, across 4 drugs with 11 or more claims each, at $38,573 in total drug cost. In 2023, CMS named 44 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Fourcand for performance year 2024, reported through an alternative payment model (APM). Dr. Fourcand accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Fourcand, published from 2020 to 2023. 2023 was the busiest year, with 3. Dr. Fourcand has published most often in Cureus. Dr. Fourcand's most frequent co-authors are Jawad F. Kirmani, MD, Ashish Kulhari, MD and Haralabos Zacharatos, DO.

Dmand AI links Dr. Fourcand to 7 clinical trials, 3 of them phase 2 studies. Conditions studied include Ischemic Stroke, Stroke and Brain Edema.

CMS Open Payments shows 98 general payments to Dr. Fourcand from 24 drug and device companies from 2019 to 2025. Travel and lodging make up the largest share, 66% of the total. Penumbra, Inc. paid the most, $6,382.

Dmand AI lists 9 awards for Dr. Fourcand, most recently Fellows Cadre in 2023. Dr. Fourcand serves on Mission Thrombectomy 2020+ (Society of Vascular and Interventional Neurology) and Stroke Education Director Young Stroke Group Speaker Circle of Rights Inc.

Dr. Fourcand graduated from FIU Herbert Wertheim College of Medicine in 2015. Dr. Fourcand is a member of AAN, American Stroke Association and Society of Vascular and Interventional Neurology.

Dr. Fourcand is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.